| Lung Abnormality Detection using Deep learning |
Harshil Soni |
System Level Solutions India Ptv.Ltd. |
NLST |
Jan 26, 2022 |
NLST-875 |
| Fully automated end to end analysis of non-small-cell lung carcinoma using deep learning techniques |
Eranga Ukwatta |
University of Guelph |
NLST |
Jan 26, 2022 |
NLST-871 |
| Unsupervised analysis of thorax CT datasets |
Marian Himstedt |
University of Luebeck |
NLST |
Jan 18, 2022 |
NLST-870 |
| Federated Validation of Lung Nodule Detection Algorithms. |
Brian Ayers |
Gesund AI |
NLST |
Jan 18, 2022 |
NLST-869 |
| BMI and the risk of renal cell carcinoma : a case control study |
Benjamin Chung |
Stanford University |
PLCO |
Jan 18, 2022 |
PLCO-896 |
| Radiomic analysis of Chest radiographs for prediction of lung cancer outcomes |
Anant Madabhushi |
Emory University |
PLCO |
Jan 18, 2022 |
PLCOI-887 |
| Interpretable AI prediction of prostate tumor staging |
Matthias Weidemüller |
Universität Heidelberg |
PLCO |
Jan 18, 2022 |
PLCO-897 |
| Pulmonary Adenocarcinoma of Low Malignant Potential |
Eric Burks |
Boston University School Of Medicine |
NLST |
Jan 7, 2022 |
NLST-867 |
| Threshold quantile regression models with applications to PSA data |
Eun Ryung Lee |
Sungkyunkwan University |
PLCO |
Jan 7, 2022 |
PLCO-893 |
| The timing between the diagnosis and the end of the last treatment in the cancer continuum in patients with colon cancer by TNM stages; and the impact of delays in the final survival of the patients, in PLCO, In the period available in the data set. |
Percy Guzman |
Percy Guzman |
PLCO |
Jan 7, 2022 |
PLCO-882 |
| Evaluating key determinants for the risk of second primary lung cancer among bladder cancer survivors using population-based screening trial data from the PLCO |
Summer Han |
Stanford University |
PLCO |
Jan 5, 2022 |
PLCO-886 |
| Development of deep learning frameworks based on pathology images for biomarker development |
Jennifer Beane |
Trustees of Boston University |
PLCO |
Jan 5, 2022 |
PLCOI-881 |
| The impact of hormone replacement therapy on cancer |
Zhaoyu Li |
University of Western Australia |
PLCO |
Dec 30, 2021 |
PLCO-883 |
| Meta-analysis of 16S head and neck cancer |
Kenny Yeo |
University of Adelaide |
PLCO |
Dec 14, 2021 |
PLCO-879 |
| Detection of prostate cancer using machine learning techniques: An exploratory study |
Laxmi Manasa Gorugantu |
Dakota State University |
PLCO |
Dec 13, 2021 |
PLCO-873 |
| Reproducibility and external validation of epidemiological risk models for endometrial cancer |
Aline Talhouk |
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada |
PLCO |
Dec 13, 2021 |
PLCO-878 |
| Breast cancer prognosis |
Lee Cooper |
Northwestern University |
PLCO |
Dec 13, 2021 |
PLCOI-877 |
| Use of Digital Pathology and Artificial Intelligence for Prostate Cancer Risk Stratification |
Eric Li |
Northwestern University Feinberg School of Medicine |
PLCO |
Dec 10, 2021 |
PLCOI-876 |
| Use of genetic ancestry versus self-reported race/ethnicity to predict lung-cancer risk in the PLCO |
Hormuzd Katki |
NCI |
PLCO |
Dec 8, 2021 |
PLCO-875 |
| Using PRS for CRC screening |
Ulrike Peters |
Fred Hutchinson Cancer Research Center |
PLCO |
Dec 8, 2021 |
PLCO-872 |
